# Cross-Hand Latent Representation for Vision-Language-Action Models

Preprint · Guangqi Jiang, Yutong Liang, Jianglong Ye, Jia-Yang Huang, Changwei Jing, Rocky Duan, Pieter Abbeel, Xiaolong Wang, Xueyan Zou

- Archive id: arxiv:2603.10158
- Published: 2026-03-10
- arXiv: https://arxiv.org/abs/2603.10158
- Citations: 0
- Source URL: https://arxiv.org/abs/2603.10158
- PDF: https://arxiv.org/pdf/2603.10158
- Provenance: arxiv

## Abstract

Dexterous manipulation is essential for real-world robot autonomy, mirroring the central role of human hand coordination in daily activity. Humans rely on rich multimodal perception--vision, sound, and language-guided intent--to perform dexterous actions, motivating vision-based, language-conditioned manipulation systems for robots. However, training reliable vision-language-action (VLA) models for dexterous manipulation requires large-scale demonstrations across many robotic hands. In addition, as new dexterous embodiments appear rapidly, collecting data for each becomes costly and impractical, creating a need for scalable cross-embodiment learning. We introduce XL-VLA, a vision-language-action framework integrated with a unified latent action space shared across diverse dexterous hands. This embodiment-invariant latent space is directly pluggable into standard VLA architectures, enabling seamless cross-embodiment training and efficient reuse of both existing and newly collected data. Experimental results demonstrate that XL-VLA consistently outperforms baseline VLA models operating in raw joint spaces, establishing it as an effective solution for scalable cross-embodiment dexterous manipulation.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Robot Learning & Embodied AI](https://space-kitty.com/topics/robotics-embodied)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.